000776:SZSEGF Securities Co., Ltd. Analysis
Data as of 2026-03-14 - not real-time
CN¥19.32
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
GF Securities is trading just above its near‑term support of ~19.25 CNY, with the RSI at a deep 24.9 indicating oversold conditions and a bearish MACD histogram confirming short‑term weakness. Volume is increasing, which could fuel a modest bounce, while the 30‑day volatility of roughly 21% and a low computed beta (~0.31) suggest limited market‑wide risk but notable price swings. The model‑based upside of over 37% and a neutral trend direction highlight a potentially attractive entry point despite the current bearish technical signal.
Fundamentally, the company posted an impressive 59% revenue growth and trades at a PE of ~11.4 versus an industry average of ~16.4, indicating it is undervalued. The dividend yield of 2.59% with a modest payout ratio (~30%) adds income appeal, but a debt‑to‑equity ratio near 300 and negative operating cash flow raise concerns about long‑term financial resilience. Analysts collectively rate the stock as a strong buy, reflecting confidence in its growth trajectory and valuation discount.
Fundamentally, the company posted an impressive 59% revenue growth and trades at a PE of ~11.4 versus an industry average of ~16.4, indicating it is undervalued. The dividend yield of 2.59% with a modest payout ratio (~30%) adds income appeal, but a debt‑to‑equity ratio near 300 and negative operating cash flow raise concerns about long‑term financial resilience. Analysts collectively rate the stock as a strong buy, reflecting confidence in its growth trajectory and valuation discount.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in oversold territory
- Price near technical support
- Increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth (~59%)
- PE well below industry average
- Attractive dividend yield with low payout
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio
- Potential regulatory tightening in Chinese capital markets
- Large cash reserves providing a cushion
Key Metrics & Analysis
Financial Health
Revenue Growth59.30%
Profit Margin40.87%
P/E Ratio11.4
ROE9.70%
ROA1.73%
Debt/Equity297.58
P/B Ratio1.2
Op. Cash FlowCN¥-63432437760
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI24.9
SupportCN¥19.25
ResistanceCN¥21.90
MA 20CN¥20.52
MA 50CN¥21.64
MA 200CN¥20.49
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceCN¥26.54
Upside/Downside37.35%
GradeUndervalued
TypeGrowth
Dividend Yield2.59%
Risk Assessment
Beta0.31
Volatility20.78%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.